Mutation of δ-sarcoglycan is associated with Ca2+- dependent vascular remodeling in the syrian hamster

American Journal of Pathology

Volumn 171, Issue 1, 2007, Pages 162-171

  Lipskaia, Larissa ^a   Pinet, Caroline ^a   Fromes, Yves ^b   Hatem, Stéphane ^a   Cantaloube, Isabelle ^a   Coulombe, Alain ^a   Lompré, Anne Marie ^a  

^a INSERM   (France)

^b Institut de Myologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; 5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLIN D1; CYCLOSPORIN A; DILTIAZEM; DYSTROPHIN; EOSIN; MIBEFRADIL; MYOSIN HEAVY CHAIN; NIFEDIPINE; TRANSCRIPTION FACTOR NFAT; CALCIUM; SARCOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DELTA SARCOGLYCAN GENE; DRUG MECHANISM; FEMALE; GENE MUTATION; MALE; MEMBRANE PERMEABILITY; MITOCHONDRION; MUSCLE CELL; MUTATOR GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYRIAN HAMSTER; THORACIC AORTA; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; WILD TYPE; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; GENETICS; HAMSTER; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; AORTA, THORACIC; APOPTOSIS; CALCIUM; CALCIUM CHANNELS; CELL PROLIFERATION; CELLS, CULTURED; CRICETINAE; DYSTROPHIN; FEMALE; MALE; MESOCRICETUS; MIBEFRADIL; MUSCLE, SMOOTH, VASCULAR; MUTATION; NFATC TRANSCRIPTION FACTORS; SARCOGLYCANS;

EID: 34547697813     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070054     Document Type: Article

References (71)

1. Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA: Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000, 106:655-662
2. Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM: Secondary coronary artery vasospasm promotes cardiomyopathy progression. Am J Pathol 2004, 164:1063-1071
3. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F: Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997, 94:13873-13878
4. Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM: Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA 1999, 96:10723-10728
5. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP: Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999, 98:465-474
6. Miyata S, Takemura G, Kawase Y, Li Y, Okada H, Maruyama R, Ushikoshi H, Esaki M, Kanamori H, Li L, Misao Y, Tezuka A, Toyo-Oka T, Minatoguchi S, Fujiwara T, Fujiwara H: Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 2006, 168:386-397
7. Wheeler MT, McNally EM: Sarcoglycans in vascular smooth and striated muscle. Trends Cardiovasc Med 2003, 13:238-243
8. Turner PR, Fong PY, Denetclaw WF, Steinhardt RA: Increased calcium influx in dystrophic muscle. J Cell Biol 1991, 115:1701-1712
9. Fong PY, Turner PR, Denetclaw WF, Steinhardt RA: Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 1990, 250:673-676
10. 2+-permeable growth factor-regulated channel. J Cell Biol 2003, 161:957-967
11. Tutdibi O, Brinkmeier H, Rudel R, Fohr KJ: Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J Physiol 1999, 515:859-868
12. Vandebrouck A, Ducret T, Basset O, Sebille S, Raymond G, Ruegg U, Gailly P, Cognard C, Constantin B: Regulation of store-operated calcium entries and mitochondrial uptake by minidystrophin expression in cultured myotubes. FASEB J 2006, 20:136-138
13. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P: Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 2002, 158:1089-1096
14. Johnson BD, Scheuer T, Catterall WA: Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. Proc Natl Acad Sci USA 2005, 102:4191-4196
15. Nakamura TY, Iwata Y, Sampaolesi M, Hanada H, Saito N, Artman M, Coetzee WA, Shigekawa M: Stretch-activated cation channels in skeletal muscle myotubes from sarcoglycan-deficient hamsters. Am J Physiol 2001, 281:C690-C699
16. Vandebrouck A, Sabourin J, Rivet J, Balghi H, Sebille S, Kitzis A, Raymond G, Cognard C, Bourmeyster N, Constantin B: Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. FASEB J 2007, 21:608-617
17. Marchand E, Constantin B, Balghi H, Claudepierre MC, Cantereau A, Magaud C, Mouzou A, Raymond G, Braun S, Cognard C: Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes. Exp Cell Res 2004, 297:363-379
18. Friedrich O, Both M, Gillis JM, Chamberlain JS, Fink RH: Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice. J Physiol 2004, 555:251-265
19. Quignard JF, Harricane MC, Menard C, Lory P, Nargeot J, Capron L, Mornet D, Richard S: Transient down-regulation of L-type Ca(2+) channel and dystrophin expression after balloon injury in rat aortic cells. Cardiovasc Res 2001, 49:177-188
20. Vallot O. Combettes L, Jourdon P, Inamo J, Marty I, Claret M, Lompre AM: Intracellular Ca(2+) handling in vascular smooth muscle cells is affected by proliferation. Arterioscler Thromb Vasc Biol 2000, 20:1225-1235
21. Lipskaia L, Lompré AM: Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell 2004, 96:55-68
22. Bading H, Ginty DD, Greenberg ME: Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993, 260:181-186
23. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI: Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997, 386:855-858
24. Lipskaia L, del Monte F, Capiod T, Yacoubi S, Hadri L, Hours M, Hajjar RJ, Lompre AM: Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res 2005, 97:488-495
25. Liu Z, Zhang C, Dronadula N, Li Q, Rao GN: Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J Biol Chem 2005, 280:14700-14708
26. Eggermont JA, Wuytack F, Verbist J, Casteels R: Expression of endoplasmic-reticulum Ca2(+)-pump isoforms and of phospholamban in pig smooth-muscle tissues. Biochem J 1990, 271:649-653
27. Marty I, Robert M, Villaz M, De Jongh K, Lai Y, Catterall WA, Ronjat M: Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle. Proc Natl Acad Sci USA 1994, 91:2270-2274
28. Lipskaia L, Pourci ML, Delomenie C, Combettes L, Goudouneche D, Paul JL, Capiod T, Lompre AM: Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ Res 2003, 92:1115-1122
29. Coulombe A, Lefevre IA, Baro I, Coraboeuf E: Barium- and calcium-permeable channels open at negative membrane potentials in rat ventricular myocytes. J Membr Biol 1989, 111:57-67
30. Lefevre T, Coraboeuf E, Ghazi A, Coulombe A: Divalent cation channels activated by phenothiazines in membrane of rat ventricular myocytes. J Membr Biol 1995, 147:147-158
31. 2+ pump? J Membr Biol 2001, 179:37-50
32. Desagher S, Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000, 10:369-377
33. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH: Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982, 66:342-354
34. Sonnenblick EH, Fein F, Capasso JM, Factor SM: Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am J Cardiol 1985, 55:179B-184B
35. Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Campbell KP: Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest 2001, 107:R1-7
36. Durbeej M, Sawatzki SM, Barresi R, Schmainda KM, Allamand V, Michele DE, Campbell KP: Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Proc Natl Acad Sci USA 2003, 100:8910-8915
37. Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally EM: Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest 2004, 113:668-675
38. Kawada T, Nakazawa M, Nakauchi S, Yamazaki K, Shimamoto R, Urabe M, Nakata J, Hemmi C, Masui F, Nakajima T, Suzuki J, Monahan J, Sato H, Masaki T, Ozawa K, Toyo-Oka T: Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters. Proc Natl Acad Sci USA 2002, 99:901-906
39. Kumamoto H, Okamoto H, Watanabe M, Onozuka H, Yoneya K, Nakagawa I, Chiba S, Watanabe S, Mikami T, Abe K, Kitabatake A: Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154. Am J Physiol 1999, 276:H1117-H1123
40. Villame J, Massicotte J, Jasmin G, Dumont L: Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster. Cardiovasc Drugs Ther 2001, 15:41-48
41. Paquette F, Jasmin G, Dumont L: Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. Cardiovasc Drugs Ther 1999, 13:525-530
42. Leuranguer V, Mangoni ME, Nargeot J, Richard S: Inhibition of T-type and L-type calcium channels by mibefradil: physiologic and pharmacologic bases of cardiovascular effects. J Cardiovasc Pharmacol 2001, 37:649-661
43. Moosmang S, Haider N, Bruderl B, Welling A, Hofmann F: Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2. Circ Res 2006, 98:105-110
44. Gackière F, Bidaux G, Lory P, Prevarskaya N, Mariot P: A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry? Cell Calcium 2006, 39:357-366
45. Schmitt R, Clozel JP, Iberg N, Buhler FR: Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vasc Biol 1995, 15:1161-1165
46. Rodman DM, Reese K, Harral J, Fouty B, Wu S, West J, Hoedt-Miller M, Tada Y, Li KX, Cool C, Fagan K, Cribbs L: Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res 2005, 96:864-872
47. Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, Wurster RD: Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 2005, 37:105-119
48. 2+ channel in glioma cell proliferation? Cell Calcium 2005, 38:593-595; author reply 597
49. Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, Lory P: Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 2000, 478:166-172
50. Golovina VA: Cell proliferation is associated with enhanced capacitative Ca(2+) entry in human arterial myocytes. Am J Physiol 1999, 277:C343-C349
51. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin LJ, Yuan JX: Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am J Physiol 2001, 280:H746-H755
52. Mignen O, Brink C, Enfissi A, Nadkarni A, Shuttleworth TJ, Giovannucci DR, Capiod T: Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells. J Cell Sci 2005, 118:5615-5623
53. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol 2006, 127:611-622
54. 2+ channels. Proc Natl Acad Sci USA 2005, 102:11112-11117
55. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC, Haller H: L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J 1998, 12:593-601
56. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 1996, 79:14-19
57. Richard S, Neveu D, Carnac G, Bodin P, Travo P, Nargeot J: Differential expression of voltage-gated Ca(2+)-currents in cultivated aortic myocytes. Biochim Biophys Acta 1992, 1160:95-104
58. Mitsuhashi S, Saito N, Watano K, Igarashi K, Tagami S, Shima H, Kikuchi K: Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster. J Biochem (Tokyo) 2003, 134:269-276
59. Ambra R, Di Nardo P, Fantini C, Minieri M, Canali R, Natella F, Virgili F: Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters. Life Sci 2002, 71:2369-2381
60. 2+ signaling. J Biol Chem 2001, 276:15018-15024
61. Suzuki E, Nishimatsu H, Satonaka H, Walsh K, Goto A, Omata M, Fujita T, Nagai R, Hirata Y: Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ Res 2002, 90:1004-1011
62. Yellaturu CR, Ghosh SK, Rao RK, Jennings LK, Hassid A, Rao GN: A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation. Biochem J 2002, 368:183-190
63. Gomez MF, Stevenson AS, Bonev AD, Hill-Eubanks DC, Nelson MT: Opposing actions of inositol 1,4,5-trisphosphate and ryanodine receptors on nuclear factor of activated T-cells regulation in smooth muscle. J Biol Chem 2002, 277:37756-37764
64. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM: γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 1998, 142:1279-1287
65. Maloyan A, Sanbe A, Osinska H, Westfall M, Robinson D, Imahashi K, Murphy E, Robbins J: Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 2005, 112:3451-3461
66. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P: Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 2003, 35:367-371
67. Haga N, Fujita N, Tsuruo T: Mitochondrial aggregation precedes cytochrome c release from mitochondria during apoptosis. Oncogene 2003, 22:5579-5585
68. Yi M, Weaver D, Hajnoczky G: Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 2004, 167:661-672
69. Robert V, Massimino ML, Tosello V, Marsault R, Cantini M, Sorrentino V, Pozzan T: Alteration in calcium handling at the subcellular level in mdx myotubes. J Biol Chem 2001, 276:4647-4651
70. 2+ channel modulates apoptosis of cardiac myocytes. FASEB J 2002, 16:99-101
71. Toyo-Oka T, Kawada T, Nakata J, Xie H, Urabe M, Masui F, Ebisawa T, Tezuka A, Iwasawa K, Nakajima T, Uehara Y, Kumagai H, Kostin S, Schaper J, Nakazawa M, Ozawa K: Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction. Proc Natl Acad Sci USA 2004, 101:7381-7385